should i switch to tirzepatide from semaglutide Switching between weight-loss medications Switching between Semaglutide and Tirzepatide?

The update reinforces that: Residual risk persists despite statin therapy Elevated triglycerides contribute to ongoing CV risk Evidence-based therapies like icosapent ethyl can help reduce CV events when added to statins in high-risk patients To view or add a comment, sign in My Publishing in Iternational Magazine Effectiveness of SGLT2 Inhibitors in Reducing Cardiovascular Risk in Non-Diabetic Patients with Underlying Coronary Heart Disease Result : The main composite outcome occurred in 6 cases (15.0%) in the SGLT2 inhibitor group in comparison to 14 patients (35.0%) in the control cohort (p = 0.041)

To improve the stability, bioactivity, and pharmacokinetics of GLP-1 analogues, SPPS also supports the addition of non-natural amino acids, PEGylation, lipidation, and other chemical modifications

doi: 10.1007/s00011-014-0768-7 131 UenoAJefferyLKobayashiTHibiTGhoshSJijonH

Number of Sessions Required Patients who desire a more elaborate and shining look may require extra effort and time